Surgery; Surgery - Vascular
The practice of vascular surgery has changed dramatically in the last decade, largely as a result of rapid adoption of technologic advances by most vascular surgeons, and I am proud and happy to be a part of this evolution. We the vascular surgeons do not consider ourselves as just surgeons, but "therapists" of vascular disease. This mainly stems from our better understanding of the natural history of vascular diseases, and their treatment. Our capability of doing both surgery and minimally-invasive procedures puts us in the best position on treat the millions of complicated patients with vascular disease. I am privileged to work with veterans with very complicated vascular problems, and we perform about 700 vascular and endovascular interventions yearly. My main areas of clinical and research interests are abdominal aortic aneurysms (esp. stent graft repair), limb salvage interventions (bypasses and angioplasty/stenting procedures), and carotid artery disease. I also have an interest in wound healing, and hold a wound clinic once a week. Hasan H. Dosluoglu, MD
Research and Professional Goals: 1. Clilnical research program: Our work at Roswell Park Cancer Institute focuses on translational research in breast cancer diagnosis and treatment, including collaborations with other clinicians and scientists in biological markers of cancer and cancer progression. 2. Health Services Research: Using a variety of data sources, we are working on methods to define and improve the quality of cancer care. The models used for this work include administrative claims data from regional payers, and multi institutional databases through national consortiums. 3. Clinical activities: We maintain a high volume, multidisciplinary program in breast cancer diagnosis and treatment at Roswell Park Cancer Institute. Teaching, clinical trials and translational research are integrated into this program at all levels.
Following his training in general surgery and surgical oncology, Dr. Gajdos was on the faculty at the University of Colorado, Department of Surgery for over seven years rising to the rank of Associate Professor of Surgery. He also served as Chief of Surgical Oncology at the Denver VA Medical Center. He quickly became one of the busiest surgical oncologists at UC and performed surgery at both hospitals on a regular basis prior to joining Stamford Health in late 2016. Dr. Gajdos has extensive experience in the surgical treatment of complex melanomas, gastrointestinal cancers (esophageal , gastric, pancreatic, hepatobiliary, colorectal) gastrointestinal stromal tumors (GIST) other sarcomas and peritoneal surface malignancies and chronic pancreatitis. A graduate of the University of Szeged (Hungary) Faculty of Medicine, Dr. Gajdos completed his residency at the University of Alabama Hospital and fellowship at the University of Michigan Health System. He is board certified in surgery. Dr Gajdos remains very active in cancer research. He has published over 70 scientific papers in prestigious medical and surgical journals. He has presented several studies at various national and international meetings. He is the recipient of faculty teaching awards at the University of Colorado and Stamford Health. Dr Gajdos started as the Chief of General Surgery at the Bullaflo VAMC and Clinical Associate Professor of Surgery in the Department of Surgery, University of Buffalo in late March.
Pediatric Surgery; Pediatric Urology; Pulmonary Disease; Surgery; Surgical Critical Care - Surgery; Thoracic Surgery; Surgery - Trauma; Surgery - Laparoscopic; Prenatal Diagnosis; Fetal Surgery; Miniature Access Surgery; Cell growth, differentiation and development; Molecular Basis of Disease
-To be a recognized leader in academic pediatric surgery (clinical surgery, clinical/basic science research, teaching and administration), -To build a state of the art surgical department, divisions, and programs congruent withthe mission goals, and needs of institutions (university, hospital, other departments), patients and their families and faculty (full time and volunteer) -To create the requiste environment for students, residents, and faculty to optimize career development -To maintain a busy clinical pratice of open and miniature access surgery for fetuses, infants, children -To cross train students (MD, RN, DDS, Phar D.,MPH, Basic Science, Residents and Fellows(all specialties), Faculty (all Health Science Schools),and Community Healthcare Professionals in the requisite MBA Skill Sets, Entrepreneurism, and Big Data analysis to optimize their professional development, careers and their patients‘ outcomes in this complicated and ever changing Healthcare environment -To be actively involved in teaching and practicing Interprofessional Care (IPC) and Interprofessional Education (IPE) -To continue to train and mentor academic gerneral surgeons -To continue to train and mentor academic pediatric surgeons -To continue to teach and mentor students at various levels -To continue laboratory and clinical incestifations in the following areas: lung development, congenital diaphragmatic hernia, fetal physiology, birth defects, prenatal diagnosis of surgical problems, fetal surgery, the genetic aspects of surgical disease, fetal frowth factors, the physiology miniature access surgery, surgical robotics, ECMO, trauma, the education process for students, residents, and fellows virtual reality, surgical simulation, telelmedicine, telesurgery, teleconferencing, telementoring, and computer applications in medicein -To continue research and development with corporate biomedical parners -To continue to advocate for children and children‘s health care
Surgery; Surgery - Laparoscopic; Bariatric Surgery; Gastrointestinal Surgery
Surgery; Transplantation; Surgery - Transplant
I conduct clinical outcomes research on hospital- and population-based data with a focus on donor selection, kidney transplantation outcomes, and delivery of high quality care. Over the last decade my research has focused on donor selection. In retrospective cohort studies of national and single center data I have examined outcomes of kidneys perceived to be suboptimal such as those declined by local centers and transplanted elsewhere, kidneys with prolonged cold ischemia time, small pediatric donor kidneys, dual kidney engraftments, kidneys with chronic lesions, donation after cardiac death donors, and donors with acute kidney injury in order to provide evidenced-based data on the magnitude of the risks associated with utilization of specific types of organs. As a result of these analyses, changes in perception of donor quality have resulted in increased kidney utilization at the centers where I have worked and invitations to share my work at other programs as well as national meetings. My research findings in this area have had a positive effect in the transplant realm since my work provides empiric evidence of acceptable outcomes of various types of kidneys that have traditionally been rejected, thus providing a basis for increased kidney utilization. With knowledge and expertise acquired through matriculation at the University of Michigan with a Masters in Clinical Research Design and Statistical Analysis I am able to analyze data myself or communicate effectively with a biostatistician. During the last 14 years I have either conducted or participated in 85 retrospective and 17 prospective studies of transplant outcomes.